Project Grant R01HD120263
- Federal Grant Award Summary The Hospital for Special Surgery Fund, Inc. (HSS Foundation) received a $267,423 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded September 16, 2025, with completion targeted for August 31, 2028. The grant funds research to develop circulating cell-free tumor DNA (ctDNA) biomarkers for assessing immunosuppressive drug...
- Federal Grant Award Summary The Hospital For Special Surgery Fund, Inc. (HSS Foundation) received a $296,093 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The award funds research investigating how endothelial cell sphingosine-1-phosphate receptor 1 (S1PR1) shapes the autoimmune response and may attenuate injury in experimental lupus nephritis. This...
- Federal Project Grant Award Summary The Hospital For Special Surgery Fund, Inc. (HSS Foundation) received a $445,217 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective September 1, 2025, through August 31, 2030. This five-year research initiative focuses on elucidating the regulatory mechanisms of osteoclasts, the multinucleated cells...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Boston Children's Hospital a $177,000 Project Grant (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) on August 20, 2025, with completion anticipated by July 31, 2027. The project delivers research services focused on identifying novel modulators of limb development and chondrocyte maturation through genome-wide functional screening. The research team will...
- Federal Grant Award Summary The Hospital for Special Surgery received a $300,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2027. The award supports research into novel mechanisms that prevent systemic lupus erythematosus (SLE), an autoimmune disease of significant military and public health relevance. The research will be conducted at the hospital's New York, NY...
- Federal Project Grant Award Summary Boston Children's Hospital received a $674,620 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025 through August 31, 2027. The award supports investigator-initiated research to elucidate the genetic and developmental basis for coordinated limb growth and proportion regulation. The research employs integrated...
- Federal Grant Award Summary Boston Children's Hospital received a $1,991,224 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025 through August 31, 2027. The award funds development of TETRIS (Trends and Epidemiology Through Real-Time Injury Surveillance), a novel pediatric injury surveillance system that applies physician-informed Natural...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $672,297 project grant award effective June 1, 2026, through September 30, 2031, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funded research addresses the regulation of heterotopic ossification (HO)—the pathological formation of bone in ectopic sites—and the...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $620,820 Project Grant awarded August 1, 2025, by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). This five-year award, concluding July 31, 2030, supports a single-arm Phase III clinical trial evaluating the efficacy of cryopreserved human umbilical cord (HUC) grafts as meningeal patches in...
- Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $472,325 Project Grant to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab) on August 4, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The project, "Quantifying Selective Motor Control in Preterm Infants: A Computer Vision Approach," will develop and validate a computer...
The Hospital For Special Surgery Fund, Inc. (HSS Foundation) received a $719,791 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded June 1, 2026, with a completion date of May 30, 2031. The research initiative focuses on developing and validating Diffusion Tensor Imaging (DTI) as a biomarker to assess physeal (growth plate) activity and predict limb bone length growth, addressing the clinical challenge of accurately forecasting final limb length in children with length discrepancies and angular deformities. The project will generate advanced imaging analysis methodologies and clinical validation data to improve surgical planning for conditions affecting approximately one-third of adults. The award funds a multi-institutional study evaluating 171 children across three major pediatric institutions to: (1) predict femoral and tibial length during adolescent growth in healthy children, (2) predict differential growth patterns in children with 2-4 centimeter limb discrepancies, and (3) assess DTI's predictive capacity for growth arrests in distal tibial physeal fractures. The research deliverables include validated DTI protocols and tractography analysis methods that characterize physeal cartilage and bone architecture, enabling identification of physeal abnormalities and providing more precise growth predictions than current indirect calculation methods. This work aims to establish DTI as a superior diagnostic tool for informing orthopedic surgical decision-making and optimizing treatment outcomes for pediatric limb length disorders.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $719.8k | 5/28/26 |